Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
AlzChem Group AG announces the start of the share repurchase program which was published by an ad hoc announcement dated February 2, 2021.
Starting February 8, 2021, AlzChem Group AG (hereinafter also referred to as the “Company”) will repurchase over a period of up to twelve months up to 50,000 no-par-value shares of the Company having a total purchase price of up to EUR 1 million (excluding ancillary purchase costs) exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA). The maximum purchase price per share (excluding ancillary purchase costs) will not exceed or fall short of the share price determined by the opening auction in XETRA trading on the trading day by more than 10 per cent. The Managing Board of AlzChem Group AG, upon authorization of the Supervisory Board, is thus exercising the authorization by the Annual General Meeting on May 14, 2019, to acquire own shares.
The purpose of the buyback is to acquire an acquisition currency that is favorable from the Company's point of view; this does not exclude the use of the acquired shares for other legally permissible purposes covered by the authorization of the Annual General Meeting.
The repurchase program will be carried out on behalf and account of AlzChem Group AG through ODDO BHF Aktiengesellschaft, Frankfurt am Main/Germany, which was commissioned by the Company. ODDO BHF Aktiengesellschaft will decide on the timing of the share purchase independently, without being influenced by the Company. The share repurchase program may be suspended and resumed at any time, in line with applicable statutory regulations.
The share repurchase program will be implemented pursuant to the trading terms of Art. 5 of the EU Regulation no 596/2014 and Art. 2 Sec..(1) of the Delegated EU Regulation no 2016/1052. Accordingly, executed repurchases will be announced in a manner compliant with the requirements of Art. 2 Sec. (3) of the Delegated EU Regulation no 2016/1052 no later than on the seventh trading day following their conclusion. In addition, AlzChem Group AG will provide regular updates on the progress of the share repurchase program at www.alzchem.com.
Trostberg, February 5, 2021
AlzChem Group AG
About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global megatrends of sustainability, population growth and healthy aging. AlzChem products offer attractive solutions in a wide range of applications.
The company sees interesting growth prospects for itself above all in the fields of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The broad product range includes, for example, dietary supplements, plant growth regulators and precursors for corona tests.
The company employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
Sabine Sieber
Head of Corporate Communications & Investor Relations
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany